Haraldseth O, Grønås T, Unsgård G
Department of Pharmacology and Toxicology, University of Trondheim, Norway.
Stroke. 1991 Sep;22(9):1188-92. doi: 10.1161/01.str.22.9.1188.
We used phosphorus-31 nuclear magnetic resonance spectroscopy in a rat model of 10 minutes' severe incomplete forebrain ischemia (two-vessel occlusion with hypotension) to study the effects of preischemic and postischemic treatment with 3 mg/kg i.v. U74006F on the recovery of high-energy phosphates and intracellular pH during early reperfusion. The mean +/- SD time to 85% recovery of phosphocreatine was 14.1 +/- 8.4 minutes in the control group (n = 10) compared with 6.6 +/- 3.5 minutes (p less than 0.05) in the preischemic (n = 8) and 4.2 +/- 1.0 minutes (p less than 0.001) in the postischemic (n = 11) treatment groups. The mean +/- SD time to 80% recovery of adenosine triphosphate was 15.4 +/- 8.5 minutes in the control group compared with 6.3 +/- 1.8 (p less than 0.005) and 5.4 +/- 2.8 (p less than 0.001) minutes in the preischemic and postischemic treatment groups, respectively. There were no differences in intracellular pH between the control and either of the treatment groups. We conclude that U74006F led to quicker recovery of high-energy phosphates during early reperfusion, and this beneficial effect was also seen with postischemic treatment.
我们在大鼠严重不完全性前脑缺血10分钟(双血管闭塞合并低血压)模型中,使用磷-31核磁共振波谱法,研究在缺血前和缺血后静脉注射3mg/kg U74006F对早期再灌注期间高能磷酸盐恢复及细胞内pH的影响。对照组(n = 10)中磷酸肌酸恢复至85%的平均±标准差时间为14.1±8.4分钟,缺血前治疗组(n = 8)为6.6±3.5分钟(p < 0.05),缺血后治疗组(n = 11)为4.2±1.0分钟(p < 0.001)。对照组中三磷酸腺苷恢复至80%的平均±标准差时间为15.4±8.5分钟,缺血前治疗组为6.3±1.8分钟(p < 0.005),缺血后治疗组为5.4±2.8分钟(p < 0.001)。对照组与任一治疗组之间细胞内pH均无差异。我们得出结论,U74006F可使早期再灌注期间高能磷酸盐更快恢复,缺血后治疗也可见此有益效果。